2007
DOI: 10.1002/pbc.21336
|View full text |Cite
|
Sign up to set email alerts
|

Corticosteroids and increased risk of readmission after acute chest syndrome in children with sickle cell disease

Abstract: Background-Acute chest syndrome (ACS) is a frequent cause of hospitalization and mortality in children with sickle cell disease. Transfusion is often required to prevent respiratory failure and treatment with dexamethasone may reduce the length of admission and the need for transfusions. We performed a retrospective cohort study to evaluate risk factors for readmission and prolonged hospitalization after different treatments for ACS.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

3
72
1

Year Published

2007
2007
2019
2019

Publication Types

Select...
7
3

Relationship

1
9

Authors

Journals

citations
Cited by 103 publications
(76 citation statements)
references
References 24 publications
3
72
1
Order By: Relevance
“…Glucocorticoids attenuate the severity of sickle-cell vaso-occlusive pain crisis, the acute chest syndrome, and the hyperhemolysis syndrome. It will be interesting to investigate in clinical studies whether enhanced Hp synthesis in these patients is among the mechanisms involved in the protective glucocorticoid effect (58)(59)(60)(61). Additionally, our data demonstrate that the Hb-Hp complex retains oxygen-binding characteristics with prolonged circulating time.…”
Section: Discussionmentioning
confidence: 97%
“…Glucocorticoids attenuate the severity of sickle-cell vaso-occlusive pain crisis, the acute chest syndrome, and the hyperhemolysis syndrome. It will be interesting to investigate in clinical studies whether enhanced Hp synthesis in these patients is among the mechanisms involved in the protective glucocorticoid effect (58)(59)(60)(61). Additionally, our data demonstrate that the Hb-Hp complex retains oxygen-binding characteristics with prolonged circulating time.…”
Section: Discussionmentioning
confidence: 97%
“…Could it be that the salutary effect of glucocorticoids in this setting is mediated partly by induction of Hp production, boosting its capacity to neutralize and clear vasculotoxic extracellular Hb? Sickle-cell vaso-occlusion sometimes can rebound in severity when the steroids are stopped or the dose is tapered (18)(19)(20). Could this be occurring because Hp levels then fall while hemolysis is still brisk, promoting once more the accumulation of plasma Hb and its consequent NO scavenging, oxidative toxicity, and acute vasculopathy?…”
Section: Figurementioning
confidence: 99%
“…Concerns over side effects, including avascular necrosis, rebound VOC (50), and association with hemorrhagic stroke (51,52), have limited enthusiasm regarding corticosteroid use in patients with SCD.…”
Section: Acs Treatmentmentioning
confidence: 99%